Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Botulinum toxin by Huons for Unspecified Musculoskeletal Disorders: Likelihood of Approval
Botulinum toxin is under clinical development by Huons and currently in Phase III for Unspecified Musculoskeletal Disorders. According to GlobalData,...
HUC-2364 by Huons for Reflux Esophagitis (Gastroesophageal Reflux Disease): Likelihood of Approval
HUC-2364 is under clinical development by Huons and currently in Phase I for Reflux Esophagitis (Gastroesophageal Reflux Disease). According to...
HUC-2344 by Huons for Type 2 Diabetes: Likelihood of Approval
HUC-2344 is under clinical development by Huons and currently in Phase I for Type 2 Diabetes. According to GlobalData, Phase...